Lmito develops a novel therapy for autoimmune disorders through a modulation of immunometabolism including a macrophage polarization.
In the fibrotic context, LMT compounds exert the anti-fibrotic effects through metabolic reprogramming of profibrotic cells in PF-ILD and IPF.
Company Details
- Employees
- 8
- Address
- Not Only #cmt1a But Also Other Neuroinflammatory And Demyelinating Conditions Such As Rheumatoid Arthritis And Ankylosing Spondylitis.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.lmito.com
Lmito Therapeutics Questions
Lmito Therapeutics's website is http://www.lmito.com
Lmito Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lmito-therapeutics
Lmito Therapeutics has
8 employees.
View email and phone details for 8
employees at Lmito Therapeutics.
Lmito Therapeutics's industry is
Biotechnology Research
Lmito Therapeutics's top competitors are
Adsc,
Amaro Therapeutics, Inc.,
Youth Bio Global,
Rudacure,
Hande Sciences,
Immunique Technologies Private Limited,
Paean Biotechnology,
Amicogen,
Xcell Therapeutics (엑셀 세라퓨틱스),
Cbt Pharmaceuticals Inc..
Lmito Therapeutics's categories are Biotechnology Research
